CI Canadian Convertible Bond ETF Common (CXF) Competitors C$9.73 -0.14 (-1.42%) As of 04/30/2025 03:06 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesBuy This Stock CXF vs. IPA, FRX, APM, ITH, GXE, CRDL, GPH, MDNA, EQ, and WMDShould you be buying CI Canadian Convertible Bond ETF Common stock or one of its competitors? The main competitors of CI Canadian Convertible Bond ETF Common include ImmunoPrecise Antibodies (IPA), Fennec Pharmaceuticals (FRX), Andean Precious Metals (APM), International Tower Hill Mines (ITH), Gear Energy (GXE), Cardiol Therapeutics (CRDL), Graphite One (GPH), Medicenna Therapeutics (MDNA), EQ (EQ), and WeedMD (WMD). These companies are all part of the "pharmaceutical products" industry. CI Canadian Convertible Bond ETF Common vs. ImmunoPrecise Antibodies Fennec Pharmaceuticals Andean Precious Metals International Tower Hill Mines Gear Energy Cardiol Therapeutics Graphite One Medicenna Therapeutics EQ WeedMD CI Canadian Convertible Bond ETF Common (TSE:CXF) and ImmunoPrecise Antibodies (CVE:IPA) are both small-cap manufacturing companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, community ranking, dividends, valuation, earnings and profitability. Does the MarketBeat Community believe in CXF or IPA? ImmunoPrecise Antibodies received 29 more outperform votes than CI Canadian Convertible Bond ETF Common when rated by MarketBeat users. However, 57.89% of users gave CI Canadian Convertible Bond ETF Common an outperform vote while only 54.79% of users gave ImmunoPrecise Antibodies an outperform vote. CompanyUnderperformOutperformCI Canadian Convertible Bond ETF CommonOutperform Votes1157.89% Underperform Votes842.11% ImmunoPrecise AntibodiesOutperform Votes4054.79% Underperform Votes3345.21% Which has stronger valuation & earnings, CXF or IPA? CI Canadian Convertible Bond ETF Common has higher earnings, but lower revenue than ImmunoPrecise Antibodies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCI Canadian Convertible Bond ETF CommonN/AN/AN/AN/AN/AImmunoPrecise AntibodiesC$19.47M8.33-C$22.19M-C$0.89-7.30 Is CXF or IPA more profitable? Company Net Margins Return on Equity Return on Assets CI Canadian Convertible Bond ETF CommonN/A N/A N/A ImmunoPrecise Antibodies N/A N/A N/A Does the media refer more to CXF or IPA? In the previous week, CI Canadian Convertible Bond ETF Common's average media sentiment score of 0.00 equaled ImmunoPrecise Antibodies'average media sentiment score. Company Overall Sentiment CI Canadian Convertible Bond ETF Common Neutral ImmunoPrecise Antibodies Neutral SummaryImmunoPrecise Antibodies beats CI Canadian Convertible Bond ETF Common on 2 of the 3 factors compared between the two stocks. Get CI Canadian Convertible Bond ETF Common News Delivered to You Automatically Sign up to receive the latest news and ratings for CXF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CXF vs. The Competition Export to ExcelMetricCI Canadian Convertible Bond ETF CommonPharmaceutical Preparations IndustryManufacturing SectorTSE ExchangeMarket CapC$49.19MC$6.89BC$2.02BC$5.65BDividend Yield4.84%3.05%2.70%6.84%P/E RatioN/A7.4422.4729.27Price / SalesN/A242.7060.32568.85Price / CashN/A65.8551.7283.07Price / BookN/A6.512.003.72Net IncomeN/AC$143.21M-C$333.48MC$300.39M7 Day Performance-1.52%1.98%0.79%0.29%1 Month Performance-3.66%6.89%-0.84%-0.19%1 Year PerformanceN/A-2.52%8.07%14.06% CI Canadian Convertible Bond ETF Common Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CXFCI Canadian Convertible Bond ETF CommonN/AC$9.73-1.4%N/A+0.5%C$49.19MN/A0.0090IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownFRXFennec PharmaceuticalsN/AC$7.08flatN/AN/AC$136.54MC$34.86M-119.9310APMAndean Precious Metals2.9331 of 5 starsC$1.29+7.5%C$2.00+55.0%N/AC$135.47MC$154.78M2.5530ITHInternational Tower Hill MinesN/AC$0.92+2.2%N/A+6.0%C$129.16MN/A-38.44220GXEGear EnergyN/AN/AN/AN/AC$126.52MC$134.93M10.391,310CRDLCardiol TherapeuticsN/AC$1.50+1.4%N/A-45.7%C$124.47MN/A-2.9520News CoverageGap UpGPHGraphite OneN/AC$0.96-2.0%N/A+21.7%C$97.20MN/A-13.8020News CoverageMDNAMedicenna TherapeuticsN/AC$1.05+1.0%N/A-50.0%C$78.56MC$4,868.39-2.8920EQEQN/AC$0.99+2.1%N/A-8.2%C$68.90MC$9.70M-14.7840Gap UpWMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap Up Related Companies and Tools Related Companies IPA Alternatives FRX Alternatives APM Alternatives ITH Alternatives GXE Alternatives CRDL Alternatives GPH Alternatives MDNA Alternatives EQ Alternatives WMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:CXF) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CI Canadian Convertible Bond ETF Common Please log in to your account or sign up in order to add this asset to your watchlist. Share CI Canadian Convertible Bond ETF Common With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CXF Stock Free CXF Stock Alerts